-
And, we are on a roll, FDA approves sotatercept, now Winrevair!
We’re buzzing with excitement in our PH community this month! The FDA has just given the green light to sotatercept, now called Winrevair, for treating PAH in adults—a breakthrough many of us have eagerly anticipated!
Our sharp Bionews News team is on the forefront again, sharing the scoop. According to them, this groundbreaking injection therapy will hit US specialty pharmacies by the end of April. Dive into the whole story through the link below.
FDA approves sotatercept, now Winrevair, to treat PAH in adults
The arrival of new treatments like this fills our PH community with hope. What are your thoughts on this fantastic news? Are you gearing up to start this much-anticipated treatment? Let’s talk about this!
Log in to reply.